INTRODUCTION {#sec1-1}
============

*Leucas* species (*Lamiaceae*) collectively recognized as "Dronpushpi," a well-known herb of ayurvedic systems of medicines is used for cough, cold, diarrhea, inflammatory skin disorders, and several other ailments. The genus comprises about 80 species and the highest diversity has been found in East Africa.\[[@ref1]\] Among them, 43 species are available in India\[[@ref2]\] as annual or perennial herbs. *Leucas aspera* (wild) is the most common species with immense medicinal values such as ulcer protective,\[[@ref3]\] antifungal, antioxidant, antimicrobial, antinociceptive, and cytotoxic activity.\[[@ref4]\] *Leucas biflora* (Vahl.) is a two-flowered perennial herb with nodal roots and many branches arise from a woody root stock. As ethnic medicine in Northern India, the mature leaf decoction is used in conjunctivitis.\[[@ref5]\] *Leucas cristata* (Roth.) Spreng, commonly known as gumma, is found abundantly in roadside areas as a weed, especially in rainy season. It possesses stimulant, laxative, diaphoretic, antiseptic, anthelmintic, insecticidal, germicidal, fungicidal, hypolipidemic, hypoglycemic, antiprotozoal, expectorant, and anti-pyretic properties.\[[@ref6]\] Foliage of *Leucas mollissima* Wall. ex Benth. is used in treating headache. The decoction is used orally to treat diabetes mellitus, hepatitis, and is effective in liver diseases.\[[@ref7]\]

A variety of chemical markers have been isolated from the *Leucas* species, which include terpenes, fatty acids, steroids, lignans, flavonoids, coumarins, various aliphatic long-chain compounds,\[[@ref8]\] phytol,\[[@ref9]\] salicylic acid, and caffeic acid.\[[@ref10]\] Several recent reports suggested the preventive role of triterpene oleanolic acid and its isomer, ursolic acid in the treatment of type-2 diabetes and other associated complications, namely nonalcoholic fatty liver disease, nephropathy, retinopathy, and atherosclerosis. The antidiabetic potential of these triterpene isomers is mediated due to target signaling of molecules that increase insulin signal transduction; reduce inflammatory and oxidative stress signaling.\[[@ref11][@ref12]\] The targeted species of *Leucas* are widely available in Northern and Central part of India and a review of literature suggested that *L. aspera* is the most utilized one. The present study includes comparative phytochemical investigation along with the evaluation of *in vitro* antidiabetic potential. The antioxidant potential was also estimated to explain the radical scavenging effect among them, as this is one of the major underlying causes of diabetes. Oleanolic acid and its isomer ursolic acid were also quantified in targeted species to authenticate their use in the management of diabetes. This also prospects for identification of an alternative/substitute of commercially exploited species, i.e. *L. aspera*.

MATERIALS AND METHODS {#sec1-2}
=====================

Chemicals {#sec2-1}
---------

Oleanolic acid (≥97% high-performance liquid chromatographic \[HPLC\]), ursolic acid (≥97% HPLC), ascorbic acid (≥97%), quercetin (≥97%), rutin (≥95%), 1-1-diphenyl-2-pic-rylhydrazyl (≥99%, DPPH), and butylated hydroxytoluene were purchased from Sigma-Aldrich. HPLC grade solvents, namely acetonitrile, methanol, water, and all other solvents/chemicals (AR grade) were purchased from Merck, Mumbai, India.

Plant materials {#sec2-2}
---------------

Aerial part of four *Leucas* species, namely *L. aspera* (LWG No. 254029), *L. biflora* (LWG No. 254030), *L. cristata* (LWG No. 254031), and *L. mollissima* (LWG No. 254033) were collected from Tendukheda forest, Tamiya, Madhya Pradesh, India, during September--October. Samples were authenticated by Dr. Sharad Srivastava, Scientist, Pharmacognosy Division, CSIR-NBRI, and voucher specimens were deposited in institute\'s herbarium. Collected samples were washed, shade dried, and powdered for further studies.

Preparation of extract {#sec2-3}
----------------------

The dried, aerial parts of *Leucas* spp. were grinded (lab grinder) and sieved through 40 mesh (up to 500 mm) to obtain fine powder. About 100 g of powdered sample was defatted with petroleum ether and then treated with methanol (ethanol stabilized) through Soxhlet extraction, until complete exhaustion of sample (7 days; 27 ± 2°C). The pooled extracts were filtered (Whatman No. 1 filter paper), concentrated in rotary evaporator under controlled conditions (50°C, 40 mbar), and finally lyophilized extracts were quantified.

Physicochemical and phytochemical characterization {#sec2-4}
--------------------------------------------------

Physicochemical parameters, namely moisture content, total ash, acid insoluble ash, and extractive values (hexane, alcohol, and water-soluble extractives), were evaluated and quantified.\[[@ref13]\] Phytochemical estimation of various primary and secondary metabolites, i.e. sugar, starch, phenolic,\[[@ref14]\] flavonoid,\[[@ref15]\] and tannin\[[@ref16]\] was also done as per the standard protocols.

High-performance liquid chromatographic quantification of oleanolic acid and its isomer ursolic acid in *Leucas* species {#sec2-5}
------------------------------------------------------------------------------------------------------------------------

Reversed phase-HPLC ultra-violet-2996 (Cyber Lab, LC 100, USA) was used for the qualitative and quantitative analysis of analytes. Chromatographic separation was performed on phenomenex C~18~ column (250 mm × 4.6 mm, 5.0 μm,) with C~18~ guard column in isocratic mode via binary mobile phase consisting of acetonitrile: Methanol (90:10) at 0.8 ml/min. Mobile phases were duly filtered through 0.22 μm millipore filter and degassed ultrasonically for 15 min before delivered to column for separation and run time was 30 min. Data acquisitions were performed using ChromeStation software. The injection volume was 25 μl for standard and sample. Detection was done at a wavelength is 210 nm.

*In vitro* (alpha amylase inhibition assay) antidiabetic activity {#sec2-6}
-----------------------------------------------------------------

### Starch--iodine color assay {#sec3-1}

Assay was carried out with slight modification based on the starch--iodine test.\[[@ref17]\] Methanol extract (500 μL) of varied concentrations were added to 500 μL of 0.02 M sodium phosphate buffer (pH 6.9 containing 6 mM sodium chloride) containing 0.04 units of α-amylase solution and were incubated at 37°C for 10 min, then 500 μL soluble starch (1% w/v) was added to each reaction well and again incubated at 37°C for 15 min. 1 M HCl (20 μL) was added to stop the enzymatic reaction, followed by the addition of 100 μL of iodine reagent (5 mM I~2~ and 5 mM KI). The color change was noted and the absorbance was read at 620 nm on a micro plate reader. The control reaction representing 100% enzyme activity did not contain any plant extract to eliminate the absorbance produced by plant extract; appropriate extract controls without the enzyme were also included. Acarbose is used as a positive control and the inhibition of enzyme activity was calculated as:

Inhibition of enzyme activity (%) = (C − S)/C × 100

Where S is the absorbance of the sample and C is the absorbance of blank (no extract).

### 3,5-dinitrosalicylic acid method {#sec3-2}

The inhibition assay was performed using 3,5-dinitrosalicylic acid (DNS) method.\[[@ref18]\] Methanol extract (500 μL) of varied concentrations were added to 500 μL of 0.02 M sodium phosphate buffer (pH 6.9 containing 6 mM sodium chloride) containing 0.04 units of α-amylase solution and were incubated at 37°C for 10 min, followed by addition of 500 μL of a 1% starch solution (0.02 M sodium phosphate buffer, pH 6.9) in all the test tubes. The reaction was stopped with 1.0 ml of DNS reagent. The test tubes were then incubated in a boiling water bath for 5 min and cooled to room temperature. The reaction mixture was then diluted after adding 10 ml of distilled water and absorbance was measured at 540 nm. The control samples were also prepared accordingly without any plant extracts and were compared with the test samples containing various concentrations of the plant extracts. Acarbose is used as a positive control and results were expressed as % inhibition calculated using the formula.

Inhibition activity (%) = Abs (control) − Abs (extract) × 100/Abs (control)

*In vitro* antioxidant activity {#sec2-7}
-------------------------------

Total flavonoid\[[@ref15]\] and phenolic\[[@ref14]\] content were expressed in terms of mg/g of quercetin equivalent (QE) and mg/g gallic acid equivalent (GAE) based on calibration curve of quercetin and gallic acid as standard. The anti-oxidant potential was analyzed via DPPH radical scavenging assay,\[[@ref19]\] ferric reducing power assay,\[[@ref20]\] and total antioxidant capacity.\[[@ref21]\]

Statistical analysis {#sec2-8}
--------------------

Results were expressed as mean ± standard deviation. Linear regression analysis was carried out for standards to calculate total phenolic and flavonoid content. IC~50~ values were obtained by GraphPad Prism 5 software (San Diego, CA, USA). One-way ANOVA followed by Student\'s *t*-test (*P* \< 0.01) was used to find the significance of *in vitro* antidiabetic and antioxidant assays.

RESULTS AND DISCUSSION {#sec1-3}
======================

Physicochemical and phytochemical studies {#sec2-9}
-----------------------------------------

Physicochemical parameters of *L. aspera*, *L. biflora*, *L. cristata*, and *L. mollissima* were studied and compared quantitatively \[[Figure 1](#F2){ref-type="fig"}\]. The study reveals that alcohol soluble extractive was highest in all the four species as compared to other extractive values; *L. biflora* shows the maximum, i.e. 24%. However, hexane and water-soluble extractive varies from 3.25--4.25% to 9.75--12.25%, respectively; however, moisture content was maximum in *L. cristata* (6.6%). Total ash and acid insoluble ash ranges between 3.27--5.05% and 0.75--2.4%, respectively. The values are observed within the specified limit of API.\[[@ref13]\]

![Physico-chemical parameter of *Leucas* species (values are mean, *n* = 3)](PM-12-159-g002){#F2}

Analysis of phytochemicals \[[Figure 2](#F3){ref-type="fig"}\] reveals that starch was found abundantly in the four species than other metabolites, and concentration ranges from 0.448% to 0.664%. Sugar, tannin, phenolic, and flavonoid content vary considerably among the species, i.e., 0.076--0.053%, 0.2--0.4%, 0.0015--0.018%, and 0.0014--0.0079%, respectively. It was observed that the species were not significantly different in the content of phytochemicals.

![Quantitative estimation of various phytochemicals in *Leucas* species (values are mean, *n* = 3)](PM-12-159-g003){#F3}

High-performance liquid chromatographic quantification of oleanolic acid and its isomer {#sec2-10}
---------------------------------------------------------------------------------------

Quantification of targeted chemical marker, namely oleanolic and ursolic acid in different *Leucas* species was carried out on the basis of calibration curve of standards. Five dilutions of standard were used in a concentration range of 0.125--1 mg/ml and various calibration values were obtained \[[Table 1](#T1){ref-type="table"}\]. Maximum concentration of oleanolic acid was found in *L. cristata*, followed to *L. mollissima*, *L. aspera*, and *L. biflora*. Ursolic acid was highest in *L. mollissima*, and then in *L. biflora*, *L. cristata*, and *L. aspera*, respectively \[Figures [3](#F4){ref-type="fig"}--[6](#F7){ref-type="fig"} and [Table 2](#T2){ref-type="table"}\].

###### 

Statistical analysis of calibration curves in high-performance liquid chromatography determination of triterpenes chemical markers

![](PM-12-159-g004)

![High-performance liquid chromatographic ultra-violet chromatogram of *Leucas aspera*](PM-12-159-g005){#F4}

![High-performance liquid chromatographic ultra-violet chromatogram of *Leucas cristata*](PM-12-159-g006){#F5}

![High-performance liquid chromatographic ultra-violet chromatogram of *Leucas mollissima*](PM-12-159-g007){#F6}

![High-performance liquid chromatographic ultra-violet chromatogram of *Leucas biflora*](PM-12-159-g008){#F7}

###### 

Quantification (%) of oleanolic acid and its isomer ursolic acid in four species of *Leucas*

![](PM-12-159-g009)

*In vitro* biological assays {#sec2-11}
----------------------------

### In vitro antidiabetic activity {#sec3-3}

*In vitro* antidiabetic activity was evaluated by α-amylase inhibition assay based on starch--iodine and DNS method. Data of starch--iodine method reveal that activity increases linearly with concentration, i.e., 0.1--0.5 mg/ml of tested plant extract \[[Figure 7a](#F8){ref-type="fig"}\]. IC~50~ follows the order, *L. mollissima* (0.75 ± 0.005) \>*L. aspera* (0.6 ± 0.01) \>*L. biflora* = *L. cristata* (0.5 ± 0.01), whereas acarbose exhibit IC~50~ at \<25 μg/ml. Results of α-amylase inhibition by DNS show that with increase in the concentration of inhibitors, degradation of starch reduces and thus indicating the inhibition of enzyme activity. The inhibition (%) by *Leucas* species varies from 9.09% to 87.95% \[[Figure 7b](#F8){ref-type="fig"}\] and acarbose exhibits 36.67--95.74% inhibition at a concentration of 10--200 μg/ml, respectively. IC~50~ of acarbose was observed at 32 ± 0.01 μg/ml, whereas within the Leucas species, IC~50~ was maximum in *L. aspera* (1.56 ± 0.01 mg/ml), followed by *L. biflora* (0.43 ± 0.05), *L. mollissima* (0.30 ± 0.01), and then *L. cristata* (0.24 ± 0.01) \[[Table 3](#T3){ref-type="table"}\]. Thus indicating that *L. cristata* exhibits the most promising activity. However, the inhibitors were significantly indifferent (*P* \< 0.01) from each other. The bioactive potential of Leucas species is suspected due to the presence of identified markers in synergy with other phytomolecules.

![(a) Anti-diabetic assay by starch-iodine color reagent. (b) Anti-diabetic assay by 3,5 dinitrosalicylic acid method color reagent](PM-12-159-g010){#F8}

###### 

IC~50~ of *Leucas* species obtained from *in-vitro* antidiabetic assay

![](PM-12-159-g011)

### In vitro antioxidant activity {#sec3-4}

Antioxidant activity of *Leucas* species were calculated by five different models having variable mechanism of action. Polyphenolic content, namely total phenolic and flavonoid content were estimated \[[Table 4](#T4){ref-type="table"}\], total phenolic content was highest in *L. aspera* (5.55 ± 0.05 mg/g GAE), followed by *L. mollissima* (0.97 ± 0.005 mg/g GAE), *L. biflora* (0.87 ± 0.005 mg/g GAE), and then *L. cristata* (0.30 ± 0.057 mg/g GAE). However, flavonoid content varies from 0.28 ± 0.005 to 1.59 ± 0.005 mg/g QE. The reducing power assay of extract served as a significant indicator of its potentiality as a reducing agent, which in turn signifies its anti-oxidant activity. Result showed that the reducing power of four species (methanolic extract) increases linearly with increase in concentration, i.e. *L. aspera*, *L. biflora*, *L. cristata*, and *L. mollissima* having regression coefficient (*r*^2^) of 0.983, 0.980, 0.888, and 0.990, respectively. This is found similar to standards, i.e. ascorbic acid (0.998), quercetin (0.997), and rutin (0.998).

###### 

Total phenolic and flavonoid content in *Leucas* species

![](PM-12-159-g012)

Free radical scavenging activity of DPPH is most widely used for screening of medicinal plants having anti-oxidant activity. The scavenging effect of DPPH radical on four *Leucas* species was concentration-dependent and varied among samples as well as standards (ascorbic acid, quercetin, and rutin) \[[Figure 8](#F9){ref-type="fig"}\]. Ascorbic acid exhibits the maximum inhibition of 77.57% (IC~50~ at 3.86 ± 0.057 μg/ml), which is followed by quercetin and rutin having inhibition of 72.43 (IC~50~ at 5.93 ± 0.115 μg/ml) and 71.48 (IC~50~ at 6.8 ± 0.173 μg/ml), respectively. *Leucas* species, namely *L. aspera*, *L. biflora*, *L. cristata*, and *L. mollissima* have IC~50~ at 1.68 ± 0.011, 0.66 ± 0.05, 1.25 ± 0.005, and 0.6 ± 0.011 mg/ml, respectively [Table 5](#T5){ref-type="table"}. However, the IC~50~ of samples was statistically different (*P* \< 0.01) than standard.

![Percentage inhibition of radical scavenging activity of *Leucas* species in 1-1-diphenyl-2-pic-rylhydrazyl assay](PM-12-159-g013){#F9}

###### 

IC~50~ value of *Leucas* spp. in 1-1-diphenyl-2-pic-rylhydrazyl radical scavenging assay

![](PM-12-159-g014)

The total antioxidant capacity of *Leucas* (methanolic extract) was measured by phosphor-molybdenum method based on regression analysis of ascorbic acid, having regression equation (y = 4.804x + 0.136) and coefficient; *r*^2^ = 0.987. Data shows that maximum total anti oxidant capacity was observed in *L. aspera* (0.411 ± 0.0005 mg/g ASE), followed by *L. mollissima* (0.172 ± 0.001 mg/g ASE), *L. biflora* (0.139 ± 0.001 mg/g ASE) and *L. cristata* having 0.131 ± 0.005 mg/g of ascorbic acid equivalent \[[Figure 9](#F10){ref-type="fig"}\]. It is observed that all the four species exhibit promising *in vitro* antioxidant activity and there is insignificant difference between them.

![Total antioxidant activity (g/g) of ascorbic acid equivalent in *Leucas* species](PM-12-159-g015){#F10}

CONCLUSION {#sec1-4}
==========

From the above study, it is inferred that bioactive triterpenes, namely oleanolic acid and ursolic acid are present in significant amount in all the evaluated species and thus exhibiting promising antidiabetic and antioxidant potential. Maximum concentration of oleanolic acid was found in *L. cristata*; however, ursolic acid was highest in *L. mollissima*. *In vitro* anti-diabetic studies showed that *L. aspera* (1.56 ± 0.01 mg/ml) and *L. mollissima* (0.75 ± 0.005 mg/ml) have significant potential. It is also evident that the potentiality of all the species as natural antioxidants and anti-diabetic were also comparable among each and hence the less explored species, i.e. *L. biflora*, *L. cristata*, and *L. mollissima* can be used as a substitute by herbal industries for *L. aspera*, which is widely recognized and exploited in various ayurvedic formulations by the name of "Dronpushpi."
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